This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101131669.
The INFRAPLUS Project Successfully Launched in Munich
October 2, 2024
We have wrapped up two intense days in Munich with satisfied faces, having made the most of every moment to celebrate the kick-off of our brand-new INFRAPLUS project. Energised discussions, plenty of ideas, and the push to implement them and take everything to the next level. INFRAFRONTIER has three exciting years ahead, during which we will expand our infrastructure’s capacity and portfolio to deliver cutting-edge in vivo models, innovative in vitro models, preclinical services, and data analysis solutions. INFRAPLUS also has a strong focus on reducing animal use in biomedical research and minimising the environmental impact of our activities.
We look forward to reaching diverse audiences and offering solutions that tackle global biomedical challenges.
3, 2, 1… Let’s go!
Check INFRAPLUS website for further details.
